pharma · COVID-19 · Cystic Fibrosis · ARCT
Arcturus Therapeutics
Arcturus Therapeutics Holdings
Arcturus Therapeutics trial registry — 16 ClinicalTrials.gov studies with program phase, status, and indication context.
10285 Science Center Dr, San Diego, California 92121, US HQ
2013 Founded
157 Employees
Public company Type
ARCT · NYSE Ticker
Company details
- Status
- Public
- HQ
- 10285 Science Center Dr, San Diego, California 92121, US
- Founded
- 2013
- Employees
- 157
- Programs
- 13
- Drugs
- 7
- Patents
- 55
Arcturus Therapeutics clinical trials
Registry index of 16 ClinicalTrials.gov studies linked to Arcturus Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Arcturus Therapeutics trial registry — 16 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Arcturus Therapeutics.
-
ARCT-032-02 — Phase 2
Clinical update -
SARS-CoV-2 mRNA Vaccine ARCT-021 — Phase 2
Clinical update -
ARCT-2303 — Phase 3
Clinical update -
ARCT-165 — Phase 2
Clinical update -
ARCT-2304 — Phase 1
Clinical update -
ARCT-2138 — Phase 1
Clinical update -
ARCT-154 Self-Amplifying RNA SARS-CoV-2 Vaccine — Phase 3
Clinical update -
ARCT-021 single dose priming — Phase 2
Clinical update